Join the club for FREE to access the whole archive and other member benefits.

Patrizia d’Alessio

CEO at AISA Therapeutics, MD PhD, hematologist and cell biologist, expert of the molecular mechanisms of inflammation

Pr. Dr. Patrizia Anna d’Alessio, MD, PhD international expert on biological mechanisms of inflammation, aging and stress.

Training in Medicine & Hematology Milan. PhD Utrecht Universities. Professor of Cell Biology Paris 5 and 11 Universities (1992-2012). Focus on cellular mechanisms of stress-induced premature senescence. Bio-guided study on plant extracts identified small non-toxic anti-inflammatory actives. 2005 French Ministry Research Award Innovative Enterprises. Founder of R&D start-up AISA Therapeutics. Three patents granted in Europe, USA, China. 2009 European FP7 Ristomed project. 2015 AISA Moleculum® trademark - a dietary supplement to relieve stress and signs of inflammation. New book : “Inflammation-body alert system” Dangles ed., launching April 2019.

Visit website: https://www.aisa-tx.com/company/

 patrizia-d-alessio-74a13415

 patri

See also: Company AISA Therapeutics - Company that develops new anti-inflammatory and anti-senescence molecules

Details last updated 12-May-2023

Patrizia d’Alessio is also referenced in the following:

4th International Conference on Aging and Disease (2023 ICAD)

27-Oct-2023 to 30-Oct-2023

Conference on Aging and Disease organized by International Society on Aging and Disease (ISOAD)

International Longevity Summit

23-Aug-2023 to 24-Aug-2023

Biotech and Longevity Conference in South Africa organized by TAFFD

Longevity Summit Dublin 2024

13-Jun-2024 to 16-Jun-2024

Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)